Aga

* After one year, most men showed an increase in the number of hairs and thicker hairs, especially in the front and temple areas. Many patients reported being more satisfied. The treat- ment was well tolerated. Only a small number had mild, temporary scalp redness or itching. No sexual or...

Key points here! * Genetic variants, including polymorphisms in the androgen receptor (AR) gene, influence individual susceptibility and therapeutic response. Highlights * Androgenetic alopecia (AGA) is the most common form of hair loss, affecting both men and women through a progressive...

Six patients with hair loss

The 20 Most Influential Hair Research Studies of 2025 A Comprehensive Review of the Year's Groundbreaking Findings in Hair Loss Treatment and Research Based on Dr. Donovan's Year-End Webinar | December 29, 2025 As we close out 2025, it's an opportune time to reflect on the remarkable advances...

* These findings represent a significant advance in a condition that affects 1.2 to 2 billion men worldwide and is recognized for its emotional and social impact. Studies show that clascoterone 5% topical solution is completely new therapeutic approach to treating AGA. In blocking...

Great documentary by Canadian journalist Brigitte Noël. Playing with the devil's candy can have dire consequences for many especially the genetically prone individuals suffering with PFS! Finasteride —or Propecia, its most well-known brand name— is a medication taken by millions of men...

Hair loss is one of those things that can feel so isolating, especially for women. But trust me, you’re not alone, and it’s not your fault. I had an amazing conversation with Dr. Omer Ibrahim, a dermatologist who’s just as passionate as I am about breaking down the stigma and getting real...

ABSTRACT We aimed to determine the efficacy of the various available oral, topical, and procedural treatment options for hair loss in individuals with androgenic alopecia. Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a systematic review of the...

The Evidence Based Hair Podcast was created by dermatologist & hair loss specialist Dr Jeff Donovan to highlight new, hot off the press, world-class research in the field of hair loss. The podcast was created for hair loss practitioners around the world who care for patients with all different...

Purpose Androgenetic alopecia (AGA) is the most common type of hair loss in humans, affecting self-esteem and emotional well-being. This study aimed to assess the safety and efficacy of VISPOTM, a standardized saw palmetto oil (2–3% β-sitosterol), in subjects with mild-to-moderate AGA...

Finasteride and dutasteride are 5-α-reductase inhibitors (5-ARIs) used to treat androgenetic alopecia (AGA). This review evaluates the efficacy of 5-ARIs for the treatment of men with AGA and the potential adverse effects on reproduction including sexual dysfunction, infertility, and...

A review discusses various treatments for androgenetic alopecia (AGA), the most common cause of hair loss. Traditional methods like minoxidil and finasteride have mixed results. Newer treatments, such as low-level laser therapy (LLLT), microneedling, platelet-rich plasma (PRP), and others, are...

Finasteride and dutasteride, known as 5-alpha reductase inhibitors (5ARIs), are used to treat benign prostatic hyperplasia and androgenetic alopecia. These drugs block the conversion of testosterone to dihydrotestosterone, which affects the neuroendocrine system. They have potential applications...

Abstract Background Oral finasteride is a well-established treatment for men with androgenetic alopecia (AGA), but long-term therapy is not always acceptable to patients. A topical finasteride formulation has been developed to minimize systemic exposure by acting specifically on hair follicles...